| Product Code: ETC9940234 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Cardiovascular Genetic Testing Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Cardiovascular Genetic Testing Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Cardiovascular Genetic Testing Market - Industry Life Cycle |
3.4 United Kingdom (UK) Cardiovascular Genetic Testing Market - Porter's Five Forces |
3.5 United Kingdom (UK) Cardiovascular Genetic Testing Market Revenues & Volume Share, By Disease, 2021 & 2031F |
3.6 United Kingdom (UK) Cardiovascular Genetic Testing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 United Kingdom (UK) Cardiovascular Genetic Testing Market Revenues & Volume Share, By Testing Type, 2021 & 2031F |
3.8 United Kingdom (UK) Cardiovascular Genetic Testing Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 United Kingdom (UK) Cardiovascular Genetic Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in the UK |
4.2.2 Growing awareness about the benefits of genetic testing for cardiovascular health |
4.2.3 Technological advancements in genetic testing leading to more accurate and affordable tests |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for genetic testing in the UK |
4.3.2 Limited reimbursement policies for genetic testing procedures |
4.3.3 Concerns regarding data privacy and security in genetic testing |
5 United Kingdom (UK) Cardiovascular Genetic Testing Market Trends |
6 United Kingdom (UK) Cardiovascular Genetic Testing Market, By Types |
6.1 United Kingdom (UK) Cardiovascular Genetic Testing Market, By Disease |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Cardiovascular Genetic Testing Market Revenues & Volume, By Disease, 2021- 2031F |
6.1.3 United Kingdom (UK) Cardiovascular Genetic Testing Market Revenues & Volume, By Inherited Cardiomyopathies, 2021- 2031F |
6.1.4 United Kingdom (UK) Cardiovascular Genetic Testing Market Revenues & Volume, By Hypertrophic Cardiomyopathy (HCM), 2021- 2031F |
6.1.5 United Kingdom (UK) Cardiovascular Genetic Testing Market Revenues & Volume, By Dilated Cardiomyopathy (DCM), 2021- 2031F |
6.1.6 United Kingdom (UK) Cardiovascular Genetic Testing Market Revenues & Volume, By Arrhythmia, 2021- 2031F |
6.1.7 United Kingdom (UK) Cardiovascular Genetic Testing Market Revenues & Volume, By Aortopathies, 2021- 2031F |
6.1.8 United Kingdom (UK) Cardiovascular Genetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United Kingdom (UK) Cardiovascular Genetic Testing Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Cardiovascular Genetic Testing Market Revenues & Volume, By Cytogenetic Testing, 2021- 2031F |
6.2.3 United Kingdom (UK) Cardiovascular Genetic Testing Market Revenues & Volume, By Biochemical Testing, 2021- 2031F |
6.2.4 United Kingdom (UK) Cardiovascular Genetic Testing Market Revenues & Volume, By Molecular Testing, 2021- 2031F |
6.3 United Kingdom (UK) Cardiovascular Genetic Testing Market, By Testing Type |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Cardiovascular Genetic Testing Market Revenues & Volume, By Predictive Testing, 2021- 2031F |
6.3.3 United Kingdom (UK) Cardiovascular Genetic Testing Market Revenues & Volume, By Carrier Testing, 2021- 2031F |
6.3.4 United Kingdom (UK) Cardiovascular Genetic Testing Market Revenues & Volume, By Prenatal and Newborn Testing, 2021- 2031F |
6.3.5 United Kingdom (UK) Cardiovascular Genetic Testing Market Revenues & Volume, By Diagnostic Testing, 2021- 2031F |
6.3.6 United Kingdom (UK) Cardiovascular Genetic Testing Market Revenues & Volume, By Pharmacogenomic Testing, 2021- 2031F |
6.3.7 United Kingdom (UK) Cardiovascular Genetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United Kingdom (UK) Cardiovascular Genetic Testing Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) Cardiovascular Genetic Testing Market Revenues & Volume, By Chromosome Analysis, 2021- 2031F |
6.4.3 United Kingdom (UK) Cardiovascular Genetic Testing Market Revenues & Volume, By Genetic Disease Diagnosis, 2021- 2031F |
6.4.4 United Kingdom (UK) Cardiovascular Genetic Testing Market Revenues & Volume, By Cardiovascular Disease Diagnosis, 2021- 2031F |
6.4.5 United Kingdom (UK) Cardiovascular Genetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
7 United Kingdom (UK) Cardiovascular Genetic Testing Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Cardiovascular Genetic Testing Market Export to Major Countries |
7.2 United Kingdom (UK) Cardiovascular Genetic Testing Market Imports from Major Countries |
8 United Kingdom (UK) Cardiovascular Genetic Testing Market Key Performance Indicators |
8.1 Adoption rate of cardiovascular genetic testing among healthcare providers |
8.2 Number of research studies and publications related to cardiovascular genetic testing in the UK |
8.3 Patient satisfaction and feedback on the effectiveness of genetic testing for cardiovascular health |
9 United Kingdom (UK) Cardiovascular Genetic Testing Market - Opportunity Assessment |
9.1 United Kingdom (UK) Cardiovascular Genetic Testing Market Opportunity Assessment, By Disease, 2021 & 2031F |
9.2 United Kingdom (UK) Cardiovascular Genetic Testing Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 United Kingdom (UK) Cardiovascular Genetic Testing Market Opportunity Assessment, By Testing Type, 2021 & 2031F |
9.4 United Kingdom (UK) Cardiovascular Genetic Testing Market Opportunity Assessment, By Application, 2021 & 2031F |
10 United Kingdom (UK) Cardiovascular Genetic Testing Market - Competitive Landscape |
10.1 United Kingdom (UK) Cardiovascular Genetic Testing Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Cardiovascular Genetic Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here